Abhishek Lenka1, Anuja Kamat2, Shivam Om Mittal3. 1. Department of Neurology MedStar Georgetown University Hospital Washington DC USA. 2. Department of Internal Medicine Texas Tech University Health Sciences Center Amarillo TX USA. 3. Department of Neurology Cleveland Clinic Abu Dhabi United Arab Emirates.
Abstract
BACKGROUND: West Nile virus (WNV) is a flavivirus that is recognized as one of the common causes of arboviral neurological disease in the world. WNV infections usually manifest with constitutional symptoms such as fever, fatigue, myalgia, rash, arthralgia, and headache. Neuroinvasive WNV infections are characterized by signs and symptoms suggestive of meningitis, encephalitis, meningoencephalitis, and acute flaccid paralysis. In addition, many patients with neuroinvasive WNV infection develop a wide range of movement disorders. This article aims to comprehensively review the spectrum and natural course of the movement disorders observed in patients with neuroinvasive WNV infections. METHODS: A literature search was performed in March 2019 (in PubMed and EMBASE) to identify articles for this review. RESULTS: Movement disorders observed in the context of WNV infections include tremor, opsoclonus-myoclonus, parkinsonism, myoclonus, ataxia, and chorea. Most often, these movement disorders resolve within a few weeks to months with an indolent course. The commonly observed tremor phenotypes include action tremor of the upper extremities (bilateral > unilateral). Tremor in patients with West Nile meningitis subsides earlier than that in patients with West Nile encephalitis/acute flaccid paralysis. Opsoclonus-myoclonus in WNV infections responds well to intravenous immunoglobulins/plasmapheresis/corticosteroids. Parkinsonism has been reported to be mild in nature and usually lasts for a few weeks to months in the majority of the patients. CONCLUSION: A wide spectrum of movement disorders is observed in neuroinvasive WNV infections. Longitudinal studies are warranted to obtain better insights into the natural course of these movement disorders.
BACKGROUND: West Nile virus (WNV) is a flavivirus that is recognized as one of the common causes of arboviral neurological disease in the world. WNV infections usually manifest with constitutional symptoms such as fever, fatigue, myalgia, rash, arthralgia, and headache. Neuroinvasive WNV infections are characterized by signs and symptoms suggestive of meningitis, encephalitis, meningoencephalitis, and acute flaccid paralysis. In addition, many patients with neuroinvasive WNV infection develop a wide range of movement disorders. This article aims to comprehensively review the spectrum and natural course of the movement disorders observed in patients with neuroinvasive WNV infections. METHODS: A literature search was performed in March 2019 (in PubMed and EMBASE) to identify articles for this review. RESULTS: Movement disorders observed in the context of WNV infections include tremor, opsoclonus-myoclonus, parkinsonism, myoclonus, ataxia, and chorea. Most often, these movement disorders resolve within a few weeks to months with an indolent course. The commonly observed tremor phenotypes include action tremor of the upper extremities (bilateral > unilateral). Tremor in patients with West Nile meningitis subsides earlier than that in patients with West Nile encephalitis/acute flaccid paralysis. Opsoclonus-myoclonus in WNV infections responds well to intravenous immunoglobulins/plasmapheresis/corticosteroids. Parkinsonism has been reported to be mild in nature and usually lasts for a few weeks to months in the majority of the patients. CONCLUSION: A wide spectrum of movement disorders is observed in neuroinvasive WNV infections. Longitudinal studies are warranted to obtain better insights into the natural course of these movement disorders.
Entities:
Keywords:
West Nile virus; ataxia; chorea; extrapyramidal; movement disorders; myoclonus; opsoclonus; parkinsonism; tremor
Authors: Karthikeyan Kanagarajan; Sivajini Ganesh; Mazen Alakhras; Eddie S Go; Rose A Recco; Muhammad M Zaman Journal: South Med J Date: 2003-06 Impact factor: 0.954
Authors: Jodie M Burton; Ralph Z Kern; William Halliday; David Mikulis; James Brunton; Margaret Fearon; Caitlin Pepperell; Cheryl Jaigobin Journal: Can J Neurol Sci Date: 2004-05 Impact factor: 2.104
Authors: Ana-Luiza Sayao; Oksana Suchowersky; Ali Al-Khathaami; Brian Klassen; Nili R Katz; Robert Sevick; Peter Tilley; Julie Fox; David Patry Journal: Can J Neurol Sci Date: 2004-05 Impact factor: 2.104
Authors: Caitlin Pepperell; Neil Rau; Sigmund Krajden; Ralph Kern; Atul Humar; Barbara Mederski; Andrew Simor; Donald E Low; Allison McGeer; Tony Mazzulli; Jodie Burton; Cheryl Jaigobin; Margaret Fearon; Harvey Artsob; Michael A Drebot; William Halliday; James Brunton Journal: CMAJ Date: 2003-05-27 Impact factor: 8.262
Authors: James J Sejvar; Maryam B Haddad; Bruce C Tierney; Grant L Campbell; Anthony A Marfin; Jay A Van Gerpen; Aaron Fleischauer; A Arturo Leis; Dobrivoje S Stokic; Lyle R Petersen Journal: JAMA Date: 2003-07-23 Impact factor: 56.272
Authors: Olga A Maximova; Daniel E Sturdevant; John C Kash; Kishore Kanakabandi; Yongli Xiao; Mahnaz Minai; Ian N Moore; Jeff Taubenberger; Craig Martens; Jeffrey I Cohen; Alexander G Pletnev Journal: Elife Date: 2021-02-18 Impact factor: 8.140
Authors: Jonathan D Krett; J David Beckham; Kenneth L Tyler; Amanda L Piquet; Lakshmi Chauhan; Carla J Wallace; Daniel M Pastula; Ronak K Kapadia Journal: Neurohospitalist Date: 2022-05-27
Authors: Luis Agüera-Ortiz; Ganesh M Babulal; Marie-Andrée Bruneau; Byron Creese; Fabrizia D'Antonio; Corinne E Fischer; Jennifer R Gatchel; Zahinoor Ismail; Sanjeev Kumar; William J McGeown; Moyra E Mortby; Nicolas A Nuñez; Fabricio F de Oliveira; Arturo X Pereiro; Ramit Ravona-Springer; Hillary J Rouse; Huali Wang; Krista L Lanctôt Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Eron G Manusov; Amalia Mora Campuzano; Omar Ahmed; Samantha Macias; Carolina Gomez de Ziegler; Gerardo Munoz Monaco Journal: Front Public Health Date: 2021-12-10